JP2010533190A - チアジアゾール誘導体の安定な製剤 - Google Patents
チアジアゾール誘導体の安定な製剤 Download PDFInfo
- Publication number
- JP2010533190A JP2010533190A JP2010516173A JP2010516173A JP2010533190A JP 2010533190 A JP2010533190 A JP 2010533190A JP 2010516173 A JP2010516173 A JP 2010516173A JP 2010516173 A JP2010516173 A JP 2010516173A JP 2010533190 A JP2010533190 A JP 2010533190A
- Authority
- JP
- Japan
- Prior art keywords
- dimethyl
- less
- pharmaceutical composition
- thiadiazol
- propionamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
以下の製剤実施例は例示であり、本発明の範囲を限定することを意図しない。
Claims (12)
- N−{4−(2,2−ジメチル−プロピオニル)−(5R)−5−[(2−エチルアミノ−エタンスルホニルアミノ)−メチル]−5−フェニル−4,5−ジヒドロ−[1,3,4]チアジアゾール−2−イル}−2,2−ジメチル−プロピオンアミド、および薬理学的に許容できる担体、希釈剤または賦形剤を溶液中に含む、医薬組成物であって、前記組成物のpHは6.4未満でありかつ2.0より大きい、医薬組成物。
- 前記組成物のpHが6.2未満でありかつ2.0より大きい、請求項1に記載の医薬組成物。
- 前記組成物のpHが5.4未満でありかつ2.0より大きい、請求項2に記載の医薬組成物。
- 前記組成物のpHが4.2未満でありかつ2.0より大きい、請求項3に記載の医薬組成物。
- N−{4−(2,2−ジメチル−プロピオニル)−(5R)−5−[(2−エチルアミノ−エタンスルホニルアミノ)−メチル]−5−フェニル−4,5−ジヒドロ−[1,3,4]チアジアゾール−2−イル}−2,2−ジメチル−プロピオンアミド、および薬理学的に許容できる担体、希釈剤または賦形剤を含む、凍結乾燥医薬組成物であって、水性希釈剤で希釈した場合の組成物のpHが6.4未満でありかつ2.0より大きい、凍結乾燥医薬組成物。
- 水性希釈剤で希釈した場合の組成物のpHが6.2未満でありかつ2.0より大きい、請求項5に記載の凍結乾燥医薬組成物。
- 水性希釈剤で希釈した場合の組成物のpHが5.4未満でありかつ2.0より大きい、請求項6に記載の凍結乾燥医薬組成物。
- 水性希釈剤で希釈した場合の組成物のpHが4.2未満でありかつ2.0より大きい、請求項6に記載の凍結乾燥医薬組成物。
- N−{4−(2,2−ジメチル−プロピオニル)−(5R)−5−[(2−エチルアミノ−エタンスルホニルアミノ)−メチル]−5−フェニル−4,5−ジヒドロ−[1,3,4]チアジアゾール−2−イル}−2,2−ジメチル−プロピオンアミド、および薬理学的に許容できる担体、希釈剤または賦形剤を含む、凍結乾燥医薬組成物であって、組成物のpHが6.4未満でありかつ2.0より大きい、凍結乾燥医薬組成物。
- 前記組成物のpHが6.2未満でありかつ2.0より大きい、請求項9に記載の凍結乾燥医薬組成物。
- 前記組成物のpHが5.4未満でありかつ2.0より大きい、請求項10に記載の凍結乾燥医薬組成物。
- 前記組成物のpHが4.2未満でありかつ2.0より大きい、請求項11に記載の凍結乾燥医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94926807P | 2007-07-12 | 2007-07-12 | |
US60/949,268 | 2007-07-12 | ||
PCT/US2008/069301 WO2009009470A1 (en) | 2007-07-12 | 2008-07-07 | Stable formulations of thiadiazole derivatiive |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2010533190A true JP2010533190A (ja) | 2010-10-21 |
JP2010533190A5 JP2010533190A5 (ja) | 2011-06-30 |
JP4875205B2 JP4875205B2 (ja) | 2012-02-15 |
Family
ID=39735000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010516173A Expired - Fee Related JP4875205B2 (ja) | 2007-07-12 | 2008-07-07 | チアジアゾール誘導体の安定な製剤 |
Country Status (28)
Country | Link |
---|---|
US (1) | US8222284B2 (ja) |
EP (1) | EP2178508B1 (ja) |
JP (1) | JP4875205B2 (ja) |
KR (1) | KR101188036B1 (ja) |
CN (1) | CN101730525A (ja) |
AR (1) | AR067472A1 (ja) |
AU (1) | AU2008275258A1 (ja) |
BR (1) | BRPI0814039A2 (ja) |
CA (1) | CA2694277C (ja) |
CL (1) | CL2008001996A1 (ja) |
CO (1) | CO6270304A2 (ja) |
CR (1) | CR11210A (ja) |
DO (1) | DOP2010000004A (ja) |
EA (1) | EA016861B1 (ja) |
EC (1) | ECSP109864A (ja) |
ES (1) | ES2401477T3 (ja) |
GT (1) | GT201000003A (ja) |
HK (1) | HK1141238A1 (ja) |
IL (1) | IL202382A0 (ja) |
MA (1) | MA31880B1 (ja) |
MX (1) | MX2010000468A (ja) |
NZ (1) | NZ581791A (ja) |
PE (1) | PE20090438A1 (ja) |
SV (1) | SV2010003449A (ja) |
TN (1) | TN2010000015A1 (ja) |
TW (1) | TW200918050A (ja) |
UA (1) | UA97672C2 (ja) |
WO (1) | WO2009009470A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010150404A1 (ja) | 2009-06-26 | 2010-12-29 | 三菱電機株式会社 | 冷媒圧縮機 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1454903B9 (en) | 2001-12-11 | 2011-10-05 | Kyowa Hakko Kirin Co., Ltd. | Thiadiazoline derivatives for treating cancer |
ES2377498T3 (es) * | 2003-04-18 | 2012-03-28 | Kyowa Hakko Kirin Co., Ltd. | Inhibidor de quinesina en etapa M |
KR20070113300A (ko) * | 2005-03-22 | 2007-11-28 | 교와 핫꼬 고교 가부시끼가이샤 | 고형종양 치료제 |
EP1870404A4 (en) * | 2005-03-22 | 2010-07-14 | Kyowa Hakko Kirin Co Ltd | MEANS FOR THE TREATMENT OF A HEMATOPOIETIC TUMOR |
JP2008137893A (ja) * | 2005-03-22 | 2008-06-19 | Kyowa Hakko Kogyo Co Ltd | 関節炎治療剤 |
JP2008150291A (ja) * | 2005-03-22 | 2008-07-03 | Kyowa Hakko Kogyo Co Ltd | 乾癬治療剤 |
JP2006265107A (ja) * | 2005-03-22 | 2006-10-05 | Kyowa Hakko Kogyo Co Ltd | 緑内障治療剤 |
EP1908755A4 (en) * | 2005-06-24 | 2009-06-24 | Kyowa Hakko Kirin Co Ltd | THERAPEUTIC AGENT AGAINST RESTENOSIS |
-
2008
- 2008-07-07 WO PCT/US2008/069301 patent/WO2009009470A1/en active Application Filing
- 2008-07-07 UA UAA201000209A patent/UA97672C2/ru unknown
- 2008-07-07 CL CL2008001996A patent/CL2008001996A1/es unknown
- 2008-07-07 EA EA201070136A patent/EA016861B1/ru not_active IP Right Cessation
- 2008-07-07 PE PE2008001141A patent/PE20090438A1/es not_active Application Discontinuation
- 2008-07-07 JP JP2010516173A patent/JP4875205B2/ja not_active Expired - Fee Related
- 2008-07-07 CA CA2694277A patent/CA2694277C/en not_active Expired - Fee Related
- 2008-07-07 TW TW097125572A patent/TW200918050A/zh unknown
- 2008-07-07 AU AU2008275258A patent/AU2008275258A1/en not_active Abandoned
- 2008-07-07 EP EP08781425A patent/EP2178508B1/en active Active
- 2008-07-07 BR BRPI0814039A patent/BRPI0814039A2/pt not_active IP Right Cessation
- 2008-07-07 MX MX2010000468A patent/MX2010000468A/es active IP Right Grant
- 2008-07-07 KR KR1020107000452A patent/KR101188036B1/ko not_active IP Right Cessation
- 2008-07-07 ES ES08781425T patent/ES2401477T3/es active Active
- 2008-07-07 AR ARP080102933A patent/AR067472A1/es not_active Application Discontinuation
- 2008-07-07 US US12/665,740 patent/US8222284B2/en not_active Expired - Fee Related
- 2008-07-07 NZ NZ581791A patent/NZ581791A/en not_active IP Right Cessation
- 2008-07-07 CN CN200880023900A patent/CN101730525A/zh active Pending
-
2009
- 2009-11-26 IL IL202382A patent/IL202382A0/en unknown
-
2010
- 2010-01-07 DO DO2010000004A patent/DOP2010000004A/es unknown
- 2010-01-07 GT GT201000003A patent/GT201000003A/es unknown
- 2010-01-08 CO CO10001885A patent/CO6270304A2/es active IP Right Grant
- 2010-01-08 TN TNP2010000015A patent/TN2010000015A1/fr unknown
- 2010-01-08 EC EC2010009864A patent/ECSP109864A/es unknown
- 2010-01-08 SV SV2010003449A patent/SV2010003449A/es not_active Application Discontinuation
- 2010-01-12 CR CR11210A patent/CR11210A/es not_active Application Discontinuation
- 2010-02-11 MA MA32616A patent/MA31880B1/fr unknown
- 2010-08-13 HK HK10107726.4A patent/HK1141238A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2008275258A1 (en) | 2009-01-15 |
KR101188036B1 (ko) | 2012-10-05 |
ECSP109864A (es) | 2010-03-31 |
TW200918050A (en) | 2009-05-01 |
KR20100029827A (ko) | 2010-03-17 |
SV2010003449A (es) | 2010-08-10 |
CA2694277A1 (en) | 2009-01-15 |
CO6270304A2 (es) | 2011-04-20 |
TN2010000015A1 (en) | 2011-09-26 |
MA31880B1 (fr) | 2010-12-01 |
EA016861B1 (ru) | 2012-08-30 |
JP4875205B2 (ja) | 2012-02-15 |
CL2008001996A1 (es) | 2009-05-22 |
UA97672C2 (ru) | 2012-03-12 |
MX2010000468A (es) | 2010-04-09 |
US8222284B2 (en) | 2012-07-17 |
US20110009458A1 (en) | 2011-01-13 |
EA201070136A1 (ru) | 2010-06-30 |
HK1141238A1 (en) | 2010-11-05 |
CN101730525A (zh) | 2010-06-09 |
PE20090438A1 (es) | 2009-04-18 |
EP2178508B1 (en) | 2013-02-06 |
AR067472A1 (es) | 2009-10-14 |
BRPI0814039A2 (pt) | 2017-10-03 |
CR11210A (es) | 2010-06-23 |
EP2178508A1 (en) | 2010-04-28 |
ES2401477T3 (es) | 2013-04-19 |
GT201000003A (es) | 2012-03-13 |
IL202382A0 (en) | 2010-06-30 |
CA2694277C (en) | 2013-04-09 |
WO2009009470A1 (en) | 2009-01-15 |
DOP2010000004A (es) | 2010-03-15 |
NZ581791A (en) | 2012-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2820827T3 (es) | Formas sólidas de un compuesto modulador de quinasas | |
ES2496144T5 (es) | Formulación de cápsulas de pirfenidona y excipientes farmacéuticamente aceptables | |
JP2020511467A (ja) | ブロモドメインを阻害する4−(1−(1,1−ジ(ピリジン−2−イル)エチル)−6−(3,5−ジメチルイソオキサゾール−4−イル)−1H−ピロロ[3,2−b]ピリジン−3−イル)安息香酸の結晶形 | |
KR102664288B1 (ko) | 카파 오피오이드 수용체 효능제의 경구 제형 | |
TWI633887B (zh) | 用於預防及/或治療多囊性腎臟病之藥物 | |
SA517381446B1 (ar) | تركيبات مضاد حيوي | |
JP6106228B2 (ja) | 過増殖性疾患、自己免疫疾患、および心疾患の治療のための3−キヌクリジノンを含有する水溶液 | |
ES2727594T3 (es) | Gránulos de liberación sostenida que contienen tacrolimus como principio activo | |
US11117870B2 (en) | Compounds, compositions, and methods for treating diseases | |
EP3127909A1 (en) | Crystalline forms of rifaximin and their preparation in the presence of amino acids | |
JP2022107687A (ja) | ペメトレキセドまたはその薬剤学的に許容可能な塩を含有する安定化された薬学組成物 | |
TW201605488A (zh) | 用以預防及/或治療多囊腎病之藥物 | |
ES2888951T3 (es) | Formulación farmacéutica | |
JP4875205B2 (ja) | チアジアゾール誘導体の安定な製剤 | |
ES2378091T5 (es) | Composiciones farmacéuticas que contienen leflunomida | |
EP4249476A1 (en) | Salt of benzothiazole compound, and crystal form and use thereof | |
ES2349410T3 (es) | Formulación farmacéutica de agente de leucotrieno b4 (ltb4) estabilizado. | |
KR100859609B1 (ko) | 테르비나핀의 말산 부가염 | |
US10695296B2 (en) | Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient | |
JP2007106736A (ja) | 注射用の医薬組成物 | |
US20090111831A1 (en) | Pharmaceutical compositions | |
AU2022331568A1 (en) | Taxol conjugate compounds, pharmaceutical compositions comprising the same, and methods for their use | |
TW201302755A (zh) | 含胺基酸穩定劑的替莫唑胺醫藥組成物及其製備方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110506 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110506 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20110506 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20110608 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110628 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110927 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111101 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111124 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141202 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |